Giredestrant
CAS No. 1953133-47-5
Giredestrant ( GDC-9545 )
产品货号. M23885 CAS No. 1953133-47-5
Giredestrant potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain.?Giredestrant has anti-tumor activity.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1887 | 有现货 |
|
5MG | ¥2341 | 有现货 |
|
10MG | ¥3750 | 有现货 |
|
25MG | ¥7063 | 有现货 |
|
50MG | ¥11259 | 有现货 |
|
100MG | ¥17658 | 有现货 |
|
200MG | ¥24057 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Giredestrant
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Giredestrant potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain.?Giredestrant has anti-tumor activity.
-
产品描述Giredestrant potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain.?Giredestrant has anti-tumor activity.?Giredestrant, a non-steroidal ER ligand, is an orally active and selective estrogen receptor (ER) antagonist.?
-
同义词GDC-9545
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体ER
-
研究领域——
-
适应症——
化学信息
-
CAS Number1953133-47-5
-
分子量522.6
-
分子式C27H31F5N4O
-
纯度>98% (HPLC)
-
溶解度DMSO:100mg/mL (191.37 mM; Need ultrasonic)
-
SMILESC[C@H](Cc1c2[nH]c3c1cccc3)N(CC(CO)(F)F)[C@@H]2c(c(F)cc(NC1CN(CCCF)C1)c1)c1F
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.C Metcalfe, et al. Abstract P5-04-07: GDC-9545: A novel ER antagonist and clinical candidate that combines desirable mechanistic and pre-clinical DMPK attributes
产品手册
关联产品
-
Estradiol benzoate
Estradiol benzoate is an estradiol analog which binds to the human, murine and chicken ERα with IC50 of 22-28 nM.
-
4-Hydroxyestrone
4-Hydroxyestrone, an endogenous estrogen metabolite, can strongly protect neuronal cells against oxidative damage.
-
4,4-Iminodiphenol
4,4'-Iminodiphenol is an inactive estrogen receptor ligand with a diphenylamine backbone.